1. Interrogating bioinspired ESIPT/PCET-based Ir(iii)-complexes as organelle-targeted phototherapeutics: a redox-catalysis under hypoxia to evoke synergistic ferroptosis/apoptosis
    Maniklal Shee et al, 2023, Chemical Science CrossRef
  2. Synthesis of Pharmacologically Potent Benzimidazole Analogs
    Jeelan Basha Nagenahalli et al, 2024, Polycyclic Aromatic Compounds CrossRef
  3. Bendamustine as a Cause of Drug-Associated Bullous Pemphigoid—A Rare Side Effect
    Preema Sinha et al, 2024, Indian Dermatology Online Journal CrossRef
  4. Design, Synthesis, Antitumor, and Antiplasmodial Evaluation of New 7-Chloroquinoline–Benzimidazole Hybrids
    Luka Krstulović et al, 2024, Molecules CrossRef
  5. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking
    Luka Krstulović et al, 2023, Molecules CrossRef
  6. LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair
    Jianli Zhou et al, 2023, Oncotarget CrossRef
  7. Risk and impact of cytomegalovirus infection in lymphoma patients treated with bendamustine
    Jen-Pei Huang et al, 2024, Annals of Hematology CrossRef
  8. Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases
    Igor Aurer et al, 2024, Biomedicines CrossRef
  9. Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
    Dan Li et al, 2024, Frontiers in Pharmacology CrossRef
  10. Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence
    Apoorv Kirti et al, 2024, Cancer Letters CrossRef
  11. Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study
    Jung Ah Lee et al, 2024, Journal of Korean Medical Science CrossRef
  12. Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?
    Dimitrios Filioglou et al, 2023, Frontiers in Immunology CrossRef
  13. Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives
    Bruno Almeida Costa et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
  14. Novel Fluorescent Benzimidazole-Hydrazone-Loaded Micellar Carriers for Controlled Release: Impact on Cell Toxicity, Nuclear and Microtubule Alterations in Breast Cancer Cells
    Rayna Bryaskova et al, 2023, Pharmaceutics CrossRef
  15. Organic Nanomaterials Loaded with Cytotoxic Agents: A Therapeutic Alternative Against Cancer
    Jorge L. Mejía-Méndez et al, 2024, null CrossRef
  16. Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy
    Yutaka Shimazu et al, 2023, Annals of Hematology CrossRef
  17. Synthesis and Biochemical Evaluation of Ethanoanthracenes and Related Compounds: Antiproliferative and Pro-Apoptotic Effects in Chronic Lymphocytic Leukemia (CLL)
    James P. McKeown et al, 2024, Pharmaceuticals CrossRef
  18. Advancements in the impact of human microbiota and probiotics on leukemia
    Yi Zhang et al, 2024, Frontiers in Microbiology CrossRef
  19. Benzimidazole‐Containing Compounds as Anticancer Agents
    Ulviye Acar Çevik et al, 2024, ChemistrySelect CrossRef
  20. Can pharmacy students use Wikipedia as a learning resource? Critical assessment of articles on chemotherapeutic drugs
    Samy A. Azer et al, 2023, Advances in Physiology Education CrossRef
  21. Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
    Davor Galusic et al, 2022, HemaSphere CrossRef
  22. Dual-Action Therapeutics: DNA Alkylation and Antimicrobial Peptides for Cancer Therapy
    Celia María Curieses Andrés et al, 2024, Cancers CrossRef